119 HR 1563 IH: Safeguarding Testing and Overdose Prevention Against Fentanyl and Xylazine Act U.S. House of Representatives 2025-02-25 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.

I119th CONGRESS1st SessionH. R. 1563IN THE HOUSE OF REPRESENTATIVESFebruary 25, 2025Ms. Crockett (for herself and Mr. Gooden) introduced the following bill; which was referred to the Committee on the Judiciary, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concernedA BILLTo amend the Controlled Substances Act to clarify that the possession, sale, purchase, importation, exportation, or transportation of drug testing equipment that tests for the presence of fentanyl or xylazine is not unlawful.

1.

Short title

This Act may be cited as the Safeguarding Testing and Overdose Prevention Against Fentanyl and Xylazine Act or the STOP Fentanyl and Xylazine Act.

2.

Clarification regarding the treatment of equipment that indicates the presence of fentanyl or xylazine in a compound

Section 422 of the Controlled Substances Act (21 U.S.C. 863) is amended by adding at the end the following: (g)

Clarification

This section does not apply to the possession, sale, purchase, importation, exportation, or transportation of equipment for which the intended use is to indicate the presence of fentanyl or xylazine in a compound..